Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Study Group. Neurology 44:S34-S42<br />
246. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB (1990) <strong>Treatment</strong> <strong>of</strong> spasticity with<br />
botulinum toxin: a double-blind study. Ann Neurol 28:512-515<br />
247. Solaro C, Lunardi GL, Capello E, Inglese M, Messmer UM, Uccelli A, Mancardi GL (1998) An open-<br />
label trial <strong>of</strong> gabapentin treatment <strong>of</strong> paroxysmal symptoms in multiple sclerosis patients.<br />
Neurology 51:609-611<br />
248. Solaro C, Messmer UM, Uccelli A, Leandri M, Mancardi GL (2000) Low-dose gabapentin combined<br />
with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in<br />
multiple sclerosis. Eur Neurol 44:45-48<br />
249. Solaro C, Uccelli MM, Brichetto G, Gasperini C, Mancardi G (2001) Topiramate relieves idiopathic<br />
and symptomatic trigeminal neuralgia. J Pain Symptom Manage 21:367-368<br />
250. Spencer KA, Yorkston KM, Duffy JR (2003) Behavioural management <strong>of</strong> respiratory/ phonatory<br />
dysfunction from dysarthria: a flow chart for guidance in clinical decision-making. J Med Speech<br />
Lang Pathol 11:xxxix-lxi<br />
251. Stank<strong>of</strong>f B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J,<br />
Lubetzki C, Clanet M, and French Modafinil Study Group (2005) Modafinil for fatigue in <strong>MS</strong>. A<br />
randomized placebo-controlled double-blind study. Neurology 64:1139-1143<br />
252. Starck M, Albrecht H, Pöllmann W, Straube A, Dieterich M (1997) Drug therapy for acquired<br />
pendular nystagmus in multiple sclerosis. J Neurol 244:9-16<br />
253. Steers WD, Meythaler JM, Haworth C, Herrell D, Park TS (1992) Effects <strong>of</strong> acute bolus and chronic<br />
continuous intrathecal bacl<strong>of</strong>en on genitourinary dysfunction due to spinal cord pathology. J<br />
Urol 148:1849-1855<br />
254. Stöhrer M, Madersbacher H, Richter R, Wehnert J, Dreikorn K (1999) Efficacy and safety <strong>of</strong><br />
propiverine in SCI-patients suffering from detrusor hyperreflexia—a double-blind, placebocontrolled<br />
clinical trial. Spinal Cord 37:196-200<br />
255. Strupp M, Schüler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, Brandt T (2003) <strong>Treatment</strong> <strong>of</strong> downbeat<br />
nystagmus with 3,4-diaminopyridine. Neurology 61:165-170<br />
256. Subak LL, Quesenberry CP, Posner SF, Cattolica E, Soghikian K (2002) The effect <strong>of</strong> behavioural<br />
therapy on urinary incontinence: a randomized controlled trial. Obstet Gynecol 100:72-78<br />
257. Surakka J, Romberg A, Ruutiainen J, Aunola S, Virtanen A, Karppi SL, Maentaka K (2004) Effects <strong>of</strong><br />
aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a<br />
randomized controlled trial. Clin Rehabil 18:737-48<br />
258. Svendsen KB, Jensen TS, Bach FW (2004) Does the cannabinoid dronabinol reduce central pain in<br />
multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 329:253<br />
259. Taylor MC, Bates CP (1979) A double-blind crossover trial <strong>of</strong> bacl<strong>of</strong>en—a new treatment for the<br />
unstable bladder syndrome. Br J Urol 51:504-505<br />
E<strong>MS</strong>P, <strong>Symptomatic</strong> <strong>Treatment</strong> <strong>of</strong> <strong>Multiple</strong> <strong>Sclerosis</strong>, December 2006 - revised in April 2008 58
Change language